# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	100	Range of duration = 0.1 to 66.15, nDeath = 1, nCensor = 25
2	AGE	ANOVA	0.267681243040922	Range of values = 52 to 88, Mean = 67.8846, StdDev = 9.52608
3	GENDER	Fisher's exact test	0.142049497144395	nTypes = 2 (FEMALE/MALE), nPatients = 13/13
4	HISTOLOGICAL.TYPE	Chi-square test	0.716303206893245	nTypes = 3 (PANCREAS-ADENOCARCINOMA DUCTAL TYPE/PANCREAS-ADENOCARCINOMA-OTHER SUBTYPE/PANCREAS-COLLOID (MUCINOUS NON-CYSTIC) CARCINOMA), nPatients = 21/4/1
5	DISTANT.METASTASIS	Chi-square test	0.412422878212507	nTypes = 3 (M0/M1/MX), nPatients = 3/1/22
6	LYMPH.NODE.METASTASIS	Chi-square test	0.171686760459992	nTypes = 3 (N0/N1/N1B), nPatients = 8/17/1
7	COMPLETENESS.OF.RESECTION	Chi-square test	0.0898810759431611	nTypes = 3 (R0/R1/RX), nPatients = 14/9/2, nMissing = 1
8	NUMBER.OF.LYMPH.NODES	ANOVA	0.507703383596322	Range of values = 0 to 11, Mean = 2.11538, StdDev = 2.59734
9	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 26
10	NEOPLASM.DISEASESTAGE	Chi-square test	0.338839911892631	nTypes = 6 (STAGE IA/STAGE IB/STAGE IIA/STAGE IIB/STAGE III/STAGE IV), nPatients = 2/1/3/18/1/1